The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy.
Dietrich N, Kolibabka M, Busch S, Bugert P, Kaiser U, Lin J, Fleming T, Morcos M, Klein T, Schlotterer A, Hammes HP.
Dietrich N, et al. Among authors: kolibabka m.
PLoS One. 2016 Dec 12;11(12):e0167853. doi: 10.1371/journal.pone.0167853. eCollection 2016.
PLoS One. 2016.
PMID: 27942008
Free PMC article.